William P. Levin

1.6k total citations
63 papers, 1.0k citations indexed

About

William P. Levin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, William P. Levin has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 16 papers in Radiation. Recurrent topics in William P. Levin's work include Lung Cancer Diagnosis and Treatment (29 papers), Advanced Radiotherapy Techniques (16 papers) and Radiation Therapy and Dosimetry (13 papers). William P. Levin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (29 papers), Advanced Radiotherapy Techniques (16 papers) and Radiation Therapy and Dosimetry (13 papers). William P. Levin collaborates with scholars based in United States, Netherlands and United Kingdom. William P. Levin's co-authors include Thomas F. DeLaney, Jay S. Loeffler, Hanne M. Kooy, Abigail T. Berman, Charles B. Simone, Stephen M. Hahn, Kristy Weber, Keith A. Cengel, Steven J. Feigenberg and Melissa A. Frick and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

William P. Levin

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William P. Levin United States	20	706	354	251	179	141	63	1.0k
Christopher D. Koprowski United States	13	717 1.0×	354 1.0×	316 1.3×	309 1.7×	136 1.0×	31	1.1k
Zvi Symon Israel	21	708 1.0×	439 1.2×	467 1.9×	362 2.0×	377 2.7×	105	1.7k
Charles Ludgate Canada	22	952 1.3×	290 0.8×	206 0.8×	234 1.3×	188 1.3×	41	1.7k
Ahmed Salem Jordan	19	438 0.6×	280 0.8×	146 0.6×	277 1.5×	197 1.4×	97	1.1k
Raphael Yechieli United States	17	294 0.4×	208 0.6×	154 0.6×	275 1.5×	178 1.3×	78	917
Iris Walraven Netherlands	18	479 0.7×	251 0.7×	143 0.6×	203 1.1×	101 0.7×	67	939
Christine E. Hill‐Kayser United States	24	469 0.7×	468 1.3×	288 1.1×	181 1.0×	158 1.1×	107	1.4k
Nina Bougatf Germany	18	415 0.6×	155 0.4×	168 0.7×	168 0.9×	146 1.0×	47	790
G. Kantor France	16	584 0.8×	307 0.9×	112 0.4×	155 0.9×	192 1.4×	87	1.1k
Mike Hawkins United Kingdom	24	415 0.6×	387 1.1×	140 0.6×	295 1.6×	133 0.9×	34	1.8k

Countries citing papers authored by William P. Levin

Since Specialization

Citations

This map shows the geographic impact of William P. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Levin more than expected).

Fields of papers citing papers by William P. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Levin. The network helps show where William P. Levin may publish in the future.

Co-authorship network of co-authors of William P. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Levin. A scholar is included among the top collaborators of William P. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Levin. William P. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yegya‐Raman, Nikhil, et al.. (2025). Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy. Radiotherapy and Oncology. 208. 110911–110911. 1 indexed citations

Lee, Sang Ho, Bolin Li, Abigail Doucette, et al.. (2023). The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiotherapy and Oncology. 190. 110030–110030. 17 indexed citations

Yegya‐Raman, Nikhil, Siqi Zhang, Roger B. Cohen, et al.. (2023). Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clinical Lung Cancer. 25(1). 50–60.e6. 7 indexed citations

Lee, Sang Ho, Bolin Li, William P. Levin, et al.. (2023). Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1435–1444. 9 indexed citations

Lee, Sang Ho, Lova Sun, Roger B. Cohen, et al.. (2023). Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation. International Journal of Radiation Oncology*Biology*Physics. 117(2). S169–S170. 1 indexed citations

Pietrofesa, Ralph A., Evguenia Arguiri, Constantinos Koumenis, et al.. (2021). Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer. The Journal of Alternative and Complementary Medicine. 27(10). 824–831. 6 indexed citations

Heijden, Michiel S. van der, Milin Acharya, Neil Beeharry, et al.. (2021). 719TiP SunRISe-1: Phase IIb study of TAR-200 in combination with cetrelimab (CET), TAR-200 alone, or CET alone in participants with high risk non-muscle invasive bladder cancer unresponsive to intravesical bacillus Calmette-Guérin who are ineligible for or elected not to undergo radical cystectomy. Annals of Oncology. 32. S723–S724. 2 indexed citations

Frick, Melissa A., Steven J. Feigenberg, Samuel Swisher‐McClure, et al.. (2020). Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy. Clinical Cancer Research. 26(10). 2372–2380. 44 indexed citations

Sun, Lova, Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy. Clinical Lung Cancer. 22(1). 58–66.e3. 30 indexed citations

10.

Jain, Varsha, Chingyun Cheng, Boon‐Keng Teo, et al.. (2020). Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 107(1). 79–87. 27 indexed citations

11.

Powles, Thomas, Michiel S. van der Heijden, D. Castellano Gauna, et al.. (2020). 697O A phase III, randomized, open-label study of first-line durvalumab (D) with or without tremelimumab (T) vs standard of care chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE). Annals of Oncology. 31. S550–S551. 16 indexed citations

12.

Barsky, Andrew R., Hui Lin, Christopher M. Wright, et al.. (2020). Initial Clinical Experience Treating Patients With Lung Cancer on a 6MV-Flattening-Filter-Free O-Ring Linear Accelerator. Cureus. 12(9). e10325–e10325. 2 indexed citations

13.

Berman, Abigail T., Melissa A. Frick, Abigail Doucette, et al.. (2019). Early Detection of Recurrence in Patients With Locally Advanced Non–Small-Cell Lung Cancer via Circulating Tumor Cell Analysis. Clinical Lung Cancer. 20(5). 384–390.e2. 20 indexed citations

14.

Schonewolf, Caitlin A., Abigail Doucette, Sunil Singhal, et al.. (2018). Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location. Clinical Lung Cancer. 20(1). e63–e71. 30 indexed citations

15.

LeBrun, Drake G., David Guttmann, Jacob E. Shabason, et al.. (2017). Predictors of Wound Complications following Radiation and Surgical Resection of Soft Tissue Sarcomas. Sarcoma. 2017. 1–7. 27 indexed citations

16.

Remick, Jill, Caitlin A. Schonewolf, Peter Gabriel, et al.. (2017). First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 18(4). 364–371. 32 indexed citations

17.

Guttmann, David, Melissa A. Frick, Ruben Carmona, et al.. (2017). A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiotherapy and Oncology. 124(2). 271–276. 28 indexed citations

18.

Vogel, Jennifer, Abigail T. Berman, Liyong Lin, et al.. (2016). Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessment. Radiotherapy and Oncology. 118(3). 504–509. 41 indexed citations

19.

Levin, William P., Hanne M. Kooy, Jay S. Loeffler, & Thomas F. DeLaney. (2005). Proton beam therapy. British Journal of Cancer. 93(8). 849–854. 255 indexed citations

20.

Graham, Thomas, et al.. (1978). Function-preserving procedures in primary reconstruction following surgery for advanced oral cancer--an appraisal.. South African Journal of Surgery. 16(3). 191. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact